Chugai Pharmaceutical Co., Ltd. announced that it obtained approval from the Ministry of Health, Labour and Welfare (MHLW) for immunosuppressant CellCept capsules 250, and CellCept powder for oral suspension 31.8% (generic name: mycophenolate mofetil) for the additional indication of prevention of gra...
AstraZeneca’s Covid-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18 years and older, to prevent Covid-19 caused by SARS-CoV-2. The Japanese Ministry of Health...